• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[微藻来源岩藻黄质油对大鼠的单次及13周经口毒性研究]

[Single and 13-week oral toxicity study of fucoxanthin oil from microalgae in rats].

作者信息

Iio Kumiko, Okada Yumika, Ishikura Masaharu

机构信息

Life Science Institute, Yamaha Motor Co., Ltd.

出版信息

Shokuhin Eiseigaku Zasshi. 2011;52(3):183-9. doi: 10.3358/shokueishi.52.183.

DOI:10.3358/shokueishi.52.183
PMID:21720124
Abstract

Single oral dose and 13-week oral subchronic toxicity studies of fucoxanthin-containing oil extracted from microalga, Chaetoseros sp., were conducted in rats. In the single oral dose study, no mortality and no change related to the test material were observed. Thus, the 50% lethal dose of microalgal fucoxanthin oil is more than 2,000 mg/kg body weight. In the 13-week oral dose study, 0, 20 or 200 mg/kg body weight of microalgal fucoxanthin oil was administered. The fucoxanthin-administered groups, showed no mortality and no abnormalities. This result suggested that the no-observed-adverse-effect level of fucoxanthin-containing oil extracted from microalga Chaetoseros sp. was 200 mg/kg body weight under the tested subchronic dose condition.

摘要

对从微藻Chaetoseros sp.中提取的含岩藻黄质的油进行了大鼠单次口服剂量和13周口服亚慢性毒性研究。在单次口服剂量研究中,未观察到死亡情况,也未观察到与受试物相关的变化。因此,微藻岩藻黄质油的半数致死剂量超过2000mg/kg体重。在13周口服剂量研究中,给予0、20或200mg/kg体重的微藻岩藻黄质油。给予岩藻黄质的组未出现死亡和异常情况。该结果表明,在受试亚慢性剂量条件下,从微藻Chaetoseros sp.中提取的含岩藻黄质的油的未观察到有害作用水平为200mg/kg体重。

相似文献

1
[Single and 13-week oral toxicity study of fucoxanthin oil from microalgae in rats].[微藻来源岩藻黄质油对大鼠的单次及13周经口毒性研究]
Shokuhin Eiseigaku Zasshi. 2011;52(3):183-9. doi: 10.3358/shokueishi.52.183.
2
[Bacterial reverse mutation test and micronucleus test of fucoxanthin oil from microalgae].[微藻岩藻黄质油的细菌回复突变试验和微核试验]
Shokuhin Eiseigaku Zasshi. 2011;52(3):190-3. doi: 10.3358/shokueishi.52.190.
3
Safety assessment of astaxanthin derived from engineered Escherichia coli K-12 using a 13-week repeated dose oral toxicity study and a prenatal developmental toxicity study in rats.利用为期13周的重复剂量经口毒性研究和大鼠产前发育毒性研究,对源自工程化大肠杆菌K-12的虾青素进行安全性评估。
Regul Toxicol Pharmacol. 2017 Jul;87:95-105. doi: 10.1016/j.yrtph.2017.05.003. Epub 2017 May 5.
4
Application of microalgal fucoxanthin for the reduction of colon cancer risk: inhibitory activity of fucoxanthin against beta-glucuronidase and DLD-1 cancer cells.微藻岩藻黄质在降低结肠癌风险中的应用:岩藻黄质对β-葡萄糖醛酸酶和DLD-1癌细胞的抑制活性。
Nat Prod Commun. 2014 Jul;9(7):921-4.
5
Toxicologic evaluations of DHA-rich algal oil in rats: developmental toxicity study and 3-month dietary toxicity study with an in utero exposure phase.富含二十二碳六烯酸(DHA)的藻类油在大鼠中的毒理学评价:发育毒性研究和 3 个月的含宫内暴露阶段的饮食毒性研究。
Food Chem Toxicol. 2012 Nov;50(11):4149-57. doi: 10.1016/j.fct.2012.08.035. Epub 2012 Aug 30.
6
Gastrointestinal Bioaccessibility and Colonic Fermentation of Fucoxanthin from the Extract of the Microalga .微藻提取物中叶黄素的胃肠道生物可及性和结肠发酵
J Agric Food Chem. 2020 Feb 19;68(7):1844-1850. doi: 10.1021/acs.jafc.9b02496. Epub 2019 May 22.
7
Anticholinesterase and antioxidant activities of fucoxanthin purified from the microalga Phaeodactylum tricornutum.从三角褐指藻中纯化的岩藻黄质的抗胆碱酯酶和抗氧化活性。
Nat Prod Commun. 2013 Oct;8(10):1381-6.
8
Safety assessment of astaxanthin-rich microalgae biomass: Acute and subchronic toxicity studies in rats.富含虾青素的微藻生物质的安全性评估:大鼠急性和亚慢性毒性研究
Food Chem Toxicol. 2008 Sep;46(9):3030-6. doi: 10.1016/j.fct.2008.05.038. Epub 2008 Jun 10.
9
Safety assessment of DHA-rich microalgae from Schizochytrium sp.裂殖壶菌属富含DHA的微藻的安全性评估
Regul Toxicol Pharmacol. 2001 Apr;33(2):205-17. doi: 10.1006/rtph.2001.1459.
10
Safety evaluation of oleic-rich triglyceride oil produced by a heterotrophic microalgal fermentation process.通过异养微藻发酵过程生产的富含油酸甘油三酯油的安全性评估。
Food Chem Toxicol. 2014 Mar;65:301-11. doi: 10.1016/j.fct.2013.12.048. Epub 2014 Jan 3.

引用本文的文献

1
Fucoxanthin-Loaded Solid Lipid Nanoparticles Exert Potent Therapeutic Efficacy in Combating High-Fat Diet Induced Obesity in Mice.负载岩藻黄质的固体脂质纳米粒在对抗高脂饮食诱导的小鼠肥胖方面具有强大的治疗效果。
Int J Mol Sci. 2025 May 29;26(11):5249. doi: 10.3390/ijms26115249.
2
Co-delivery of fucoxanthin and Twist siRNA using hydroxyethyl starch-cholesterol self-assembled polymer nanoparticles for triple-negative breast cancer synergistic therapy.使用羟乙基淀粉-胆固醇自组装聚合物纳米颗粒共递送岩藻黄质和Twist小干扰RNA用于三阴性乳腺癌的协同治疗。
J Adv Res. 2025 Apr;70:463-479. doi: 10.1016/j.jare.2024.04.017. Epub 2024 Apr 16.
3
Fucoxanthin Inhibits Development of Sigmoid Colorectal Cancer in a PDX Model With Alterations of Growth, Adhesion, and Cell Cycle Signals.
岩藻黄质抑制具有生长、黏附和细胞周期信号改变的 PDX 模型中乙状结肠直肠癌的发展。
Cancer Genomics Proteomics. 2023 Dec;20(6suppl):686-705. doi: 10.21873/cgp.20416.
4
The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease.姜黄素在非酒精性脂肪性肝病中的作用。
Int J Mol Sci. 2023 May 3;24(9):8203. doi: 10.3390/ijms24098203.
5
A Review of the Effects of Fucoxanthin on NAFLD.综述岩藻黄质对非酒精性脂肪性肝病的影响。
Nutrients. 2023 Apr 19;15(8):1954. doi: 10.3390/nu15081954.
6
Fucoxanthin: A Promising Phytochemical on Diverse Pharmacological Targets.岩藻黄质:一种针对多种药理学靶点的有前景的植物化学物质。
Front Pharmacol. 2022 Aug 2;13:929442. doi: 10.3389/fphar.2022.929442. eCollection 2022.
7
The Potential of the Marine Microalga in the Prevention of Obesity and Metabolic Syndrome in High-Fat-Fed Wistar Rats.海洋微藻在预防高脂肪喂养 Wistar 大鼠肥胖和代谢综合征中的潜力。
Molecules. 2022 Jun 30;27(13):4246. doi: 10.3390/molecules27134246.
8
Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer.岩藻黄质是治疗乳腺癌的一种潜在治疗剂。
Mar Drugs. 2022 May 30;20(6):370. doi: 10.3390/md20060370.
9
Requirement of CLIC4 Expression in Human Colorectal Cancer Cells for Sensitivity to Growth Inhibition by Fucoxanthinol.CLIC4 在人结直肠癌细胞中对岩藻黄质抑制生长敏感性的需求。
Cancer Genomics Proteomics. 2022 Jul-Aug;19(4):428-444. doi: 10.21873/cgp.20330.
10
Fucoxanthin from Algae to Human, an Extraordinary Bioresource: Insights and Advances in up and Downstream Processes.藻源岩藻黄素:一种非凡的生物资源——上下游工艺的进展与展望。
Mar Drugs. 2022 Mar 23;20(4):222. doi: 10.3390/md20040222.